The B‐cell receptor in control of tumor B‐cell fitness: Biology and clinical relevance

Stefano Casola(IFOM), Fabio Facchetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Maurilio Ponzoni(San Raffaele University of Rome), Paola Sindaco(University of Bari Aldo Moro), Laura Perucho(Vita-Salute San Raffaele University), Claudio Tripodo(University of Palermo)
Immunological Reviews
March 1, 2019
10.1111/imr.12738
Cited by 20

Related Papers

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
|Nature Immunology|2006|771
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
B cell receptor signal strength determines B cell fate
|Nature Immunology|2004|556